An exciting development in the field of neurodegeneration is the association between the
rare monogenic disorder Gaucher disease and the common complex disorder Parkinson …

The respiratory tract is commonly affected in multisystem disorders. Although many drugs
have been developed to target various components of these diseases, there is still a need …

Early onset Parkinson's disease (EOPD) has been recently defined as a clinical entity with
subjects presenting with Parkinson's disease (PD) between the ages of 21-50 and replaces …

Abstract Brain Organiods (BOs) are a promising technique for researching disease
progression in the human brain. These organoids, which are produced from human induced …

Introduction Parkinson's disease (PD) is a complex disorder with vast clinical heterogeneity.
Recent genetic, imaging and clinical evidence suggest that there are multiple subtypes of …

Ambroxol, a commonly used mucolytic agent, has been extensively studied for its clinical
effectiveness in managing respiratory conditions in pediatric and adult patients. The existing …

Background Variants in the GBA1 gene are the commonest genetic risk factor for Parkinson
disease (PD). Genotype-phenotype correlations exist but with conflicting data, particularly in …